0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Hormone Replacement Therapy and Risk of Breast Cancer

Ellen C. G. Grant, MD
JAMA. 2002;287(18):2360-2361. doi:10.1001/jama.287.18.2359.
Text Size: A A A
Published online

Extract

To the Editor: Dr Chen and colleagues1 found that use of hormone replacement therapy (HRT) for 20 to 60 months within the previous 5 years increased the incidence of breast cancer by 60% to 85%. They also found that current use of estrogens doubled the risk of lobular breast cancer, but current use of estrogen plus progestin combination increased the risk 4-fold, or twice as much again.

It would be of interest to know how many women in this study had never used hormones. Did ever-users of both HRT and oral contraceptives (OCs) have more hormone receptor–positive cancers? Similarly, Chen et al did not measure the effect of very short HRT use because women receiving a single 3-month supply were excluded. However, prescription data in the United Kingdom suggest that most women take HRT for only 9 months.2 One UK study of HRT excluded women who did not complete a year of therapy.3 In contrast, another UK study found that 1-year use of progestin-only contraceptives increased the risk of breast cancer by 35%, with few women having longer use.4

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();